Lung cancer Posts on Medivizor
Navigation Menu

Lung cancer Posts on Medivizor

Nanodrugs

Nanodrugs

Posted by on Jun 29, 2019 in Blog, Breast cancer, Colorectal cancer, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Parkinson's Disease, Prostate cancer | 0 comments

Nanodrugs have been around for some time. In fact, over 250 drugs using nanotechnology that  have been approved by the FDA and are in clinical use. The name nanodrug or nanopharmaceuticals refers to the size of the particle that is created to house the medication. A nano is very tiny: nanoparticles are between 1 and 100 nanometers in at least one of its...

Read More

Looking patients with metastatic non small cell lung cancer to trial a radiation treatment

Posted by on Jun 29, 2019 in Lung cancer | 0 comments

In a nutshell This phase 2 trial will investigate the effectiveness of stereotactic body radiotherapy (SBRT) in patients with metastatic cancer. The main outcome will be progression-free survival (PFS; survival without the cancer getting worse).  This trial is recruiting in multiple locations in New York and New Jersey, US. The details...

Read More

Searching for patients with previously treated non-small cell lung cancer to trial an immunotherapy combination

Posted by on Jun 29, 2019 in Lung cancer | 0 comments

In a nutshell This study wanted to find out if treating recurrent non-small cell lung cancer with ramucirumab (Cyramza) and pembrolizumab (Keytruda) works better than standard care practices. The main outcome that will be measured is the overall survival rates.  This study will take place in the United States. The details There are a...

Read More

Search for patients with relapsed or unresponsive small cell lung cancer to try a treatment combination

Posted by on Jun 29, 2019 in Lung cancer | 0 comments

In a nutshell This study wants to find out how well talazoparib (Talzenna) and temozolomide (Temodal) work for treating patients with small cell lung cancer that has come back after or was unresponsive to initial chemotherapy. The main outcome that will be measured is how long the patients go before the cancer grows. The study is...

Read More

Searching for patients with non-small cell lung cancer to test this new treatment combination

Posted by on Jun 24, 2019 in Lung cancer | 0 comments

In a nutshell This phase 2 trial is examining the effectiveness and safety of navarixin (MK-7123) in combination with pembrolizumab (Keytruda) in patients with non-small cell lung cancer (NSCLC). The main outcome to be measured will be the objective response rate (ORR; tumor shrinkage or disappearance).  The details A treatment option for...

Read More

Searching for patients with lung cancer that cannot be operated on to test durvalumab after chemotherapy and radiation

Posted by on Jun 24, 2019 in Lung cancer | 0 comments

In a nutshell This phase 2 trial will investigate the safety and effectiveness of durvalumab (Imfinzi) in patients with stage III non-small cell lung cancer (NSCLC).  The main outcomes will be the number of treatment-related adverse events (TRAEs) and progression-free survival (PFS).  The details Non-small cell lung cancer (NSCLC)...

Read More